Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The associations between duration of untreated psychosis, growth factors, and neurocognition in patients with drug-naïve schizophrenia

16 Sept 2024

Abstract excerpt

BACKGROUND: Cognitive impairment is a core feature of schizophrenia with unclear mechanisms, particularly neurocognition. The objective of this study was to investigate the association between duration of untreated psychosis (DUP) and neurocognition, as well as potential biological mechanisms. METHODS: A total of 219 patients were recruited in this study. DUP was measured in years, reflecting the untreated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neurogenesis and neuroplasticity mechanisms
Share to Schizophrenia research and treatment
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39288474
DOI: 10.1016/j.schres.2024.09.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The associations between duration of untreated psychosis, growth factors, and neurocognition in patients with drug-naïve schizophreniaPMID 39288474Read ↗

Neurocognition in the extended psychosis phenotype: performance of a community sample of adolescents with psychotic symptoms on the MATRICS neurocognitive battery.Semantic proximity Read ↗

Cognitive deficits in clinical high risk, genetically at high-risk for psychosis and patients with first-episode schizophreniaSemantic proximity Read ↗

Neurocognitive growth charting in psychosis spectrum youths.Semantic proximity Read ↗

Transdiagnostic neurocognitive deficits in patients with type 2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia: A 1-year follow-up studySemantic proximity Read ↗

Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.Semantic proximity Read ↗

Neurocognitive impairments in nonpsychotic parents of children with schizophrenia and attention-deficit/hyperactivity disorder: the University of California, Los Angeles Family Study.Semantic proximity Read ↗

The Differences in Cognitive Deficits Among Older Adult Patients with Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder: The Results of a Chart Review Study From 1997 to 2017Semantic proximity Read ↗

Neurocognition and its association with adverse childhood experiences and familial risk of mental illnessSemantic proximity Read ↗

The moderating role of COMT gene rs4680 polymorphism between maladaptive metacognitive beliefs and negative symptoms in patients with schizophreniaSemantic proximity Read ↗

Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?Semantic proximity Read ↗

Reaction time of the Continuous Performance Test is an endophenotypic marker for schizophrenia: a study of first-episode neuroleptic-naive schizophrenia, their non-psychotic first-degree relatives and healthy population controls.Semantic proximity Read ↗

AKT1 and neurocognition in schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.